Soleno Therapeutics, Inc. · NASDAQ:SLNO
BlackRock, Inc. reported a 5.50% stake in Soleno Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc. reported a 5.50% stake in Soleno Therapeutics, Inc., 2,766,225 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 2,766,225
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.50% | 2,766,225 |
Source
Related
- Soleno Therapeutics, Inc.
- BlackRock, Inc.
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 24, 2026
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026